{"entity":{"type":"insider","cik":"0001817320","url":"/insider/0001817320","json_url":"/insider/0001817320.json","name":"Cormorant Private Healthcare Fund III LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":26,"first":"2020-11-23","last":"2026-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Cormorant Private Healthcare Fund III LP","source":"filing","n_filings":26,"first_seen":"2020-11-23","last_seen":"2026-08-10"}],"transactions":[{"id":9276040,"accession":"0001231919-26-000852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000852","line_url":"/filing/0001231919-26-000852#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BlossomHill Therapeutics, Inc.","issuer_ticker":"BLSM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund V LP; Cormorant Private Healthcare Fund VI, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":3614034.0,"shares_owned_after_display":"3,614,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-10","scope":"insider"},{"id":4192953,"accession":"0000929638-25-003712","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000929638-25-003712","line_url":"/filing/0000929638-25-003712#line-5","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5827.0,"shares_display":"5,827","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":40555.92,"total_display":"40,555.92","total_whole":"40,556","shares_owned_after":1994173.0,"shares_owned_after_display":"1,994,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-01","scope":"insider"},{"id":4192948,"accession":"0000929638-25-003712","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000929638-25-003712","line_url":"/filing/0000929638-25-003712","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6494151.0,"shares_display":"6,494,151","price_per_share":7.210739045026825,"price_display":"7.21","price_state":"stated","total_value":46827628.18,"total_display":"46,827,628.18","total_whole":"46,827,628","shares_owned_after":4800000.0,"shares_owned_after_display":"4,800,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider","n_lines":4},{"id":5149439,"accession":"0000929638-25-001950","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-001950","line_url":"/filing/0000929638-25-001950#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813439.0,"shares_display":"1,813,439","price_per_share":1.8545,"price_display":"1.85","price_state":"stated","total_value":3363022.6255,"total_display":"3,363,022.63","total_whole":"3,363,023","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4574246,"accession":"0000929638-25-001870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-001870","line_url":"/filing/0000929638-25-001870#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24300.0,"shares_display":"24,300","price_per_share":1.985,"price_display":"1.98","price_state":"stated","total_value":48235.5,"total_display":"48,235.50","total_whole":"48,236","shares_owned_after":1813439.0,"shares_owned_after_display":"1,813,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-14","scope":"insider"},{"id":2107561,"accession":"0000929638-24-001336","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000929638-24-001336","line_url":"/filing/0000929638-24-001336","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":2.9004525,"price_display":"2.90","price_state":"stated","total_value":1160181.0,"total_display":"1,160,181.00","total_whole":"1,160,181","shares_owned_after":2895273.0,"shares_owned_after_display":"2,895,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":8},{"id":2818091,"accession":"0000929638-24-001046","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000929638-24-001046","line_url":"/filing/0000929638-24-001046#line-5","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":2.141,"price_display":"2.14","price_state":"stated","total_value":856400.0,"total_display":"856,400.00","total_whole":"856,400","shares_owned_after":3295273.0,"shares_owned_after_display":"3,295,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-18","scope":"insider"},{"id":2818086,"accession":"0000929638-24-001046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000929638-24-001046","line_url":"/filing/0000929638-24-001046","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":509091.0,"shares_display":"509,091","price_per_share":3.717612941497689,"price_display":"3.72","price_state":"stated","total_value":1892603.29,"total_display":"1,892,603.29","total_whole":"1,892,603","shares_owned_after":3859098.0,"shares_owned_after_display":"3,859,098","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-18","scope":"insider","n_lines":4},{"id":8245482,"accession":"0000929638-23-002829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002829","line_url":"/filing/0000929638-23-002829#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma, Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1307311.0,"shares_display":"1,307,311","price_per_share":6.9911,"price_display":"6.99","price_state":"stated","total_value":9139541.9321,"total_display":"9,139,541.93","total_whole":"9,139,542","shares_owned_after":11231000.0,"shares_owned_after_display":"11,231,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-23","filed_date":"2023-10-25","scope":"insider"},{"id":8645506,"accession":"0000929638-23-002739","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002739","line_url":"/filing/0000929638-23-002739#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58839.0,"shares_display":"58,839","price_per_share":59.8973,"price_display":"59.90","price_state":"stated","total_value":3524297.2347,"total_display":"3,524,297.23","total_whole":"3,524,297","shares_owned_after":8494151.0,"shares_owned_after_display":"8,494,151","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-10","scope":"insider"},{"id":8281367,"accession":"0000929638-23-002692","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000929638-23-002692","line_url":"/filing/0000929638-23-002692#line-3","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67814.0,"shares_display":"67,814","price_per_share":57.3188,"price_display":"57.32","price_state":"stated","total_value":3887017.1032,"total_display":"3,887,017.10","total_whole":"3,887,017","shares_owned_after":8435312.0,"shares_owned_after_display":"8,435,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-04","scope":"insider"},{"id":8281363,"accession":"0000929638-23-002692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-23-002692","line_url":"/filing/0000929638-23-002692#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150487.0,"shares_display":"150,487","price_per_share":57.252,"price_display":"57.25","price_state":"stated","total_value":8615681.724,"total_display":"8,615,681.72","total_whole":"8,615,682","shares_owned_after":8367498.0,"shares_owned_after_display":"8,367,498","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-04","scope":"insider"},{"id":8281358,"accession":"0000929638-23-002692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002692","line_url":"/filing/0000929638-23-002692#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74911.0,"shares_display":"74,911","price_per_share":57.37,"price_display":"57.37","price_state":"stated","total_value":4297644.07,"total_display":"4,297,644.07","total_whole":"4,297,644","shares_owned_after":8217011.0,"shares_owned_after_display":"8,217,011","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":8352607,"accession":"0000929638-23-002564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-23-002564","line_url":"/filing/0000929638-23-002564#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":751233.0,"shares_display":"751,233","price_per_share":9.2447,"price_display":"9.24","price_state":"stated","total_value":6944923.7151,"total_display":"6,944,923.72","total_whole":"6,944,924","shares_owned_after":69465823.0,"shares_owned_after_display":"69,465,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-19","scope":"insider"},{"id":8352602,"accession":"0000929638-23-002564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-002564","line_url":"/filing/0000929638-23-002564#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1401505.0,"shares_display":"1,401,505","price_per_share":9.0479,"price_display":"9.05","price_state":"stated","total_value":12680677.0895,"total_display":"12,680,677.09","total_whole":"12,680,677","shares_owned_after":68714590.0,"shares_owned_after_display":"68,714,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-19","scope":"insider"},{"id":8464158,"accession":"0000929638-23-001211","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000929638-23-001211","line_url":"/filing/0000929638-23-001211#line-3","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":886634.0,"shares_display":"886,634","price_per_share":11.6003,"price_display":"11.60","price_state":"stated","total_value":10285220.3902,"total_display":"10,285,220.39","total_whole":"10,285,220","shares_owned_after":67313085.0,"shares_owned_after_display":"67,313,085","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-20","scope":"insider"},{"id":8464154,"accession":"0000929638-23-001211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-23-001211","line_url":"/filing/0000929638-23-001211#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":951909.0,"shares_display":"951,909","price_per_share":11.1485,"price_display":"11.15","price_state":"stated","total_value":10612357.4865,"total_display":"10,612,357.49","total_whole":"10,612,357","shares_owned_after":66426451.0,"shares_owned_after_display":"66,426,451","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-19","filed_date":"2023-04-20","scope":"insider"},{"id":8464149,"accession":"0000929638-23-001211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-001211","line_url":"/filing/0000929638-23-001211#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3376646.0,"shares_display":"3,376,646","price_per_share":11.2695,"price_display":"11.27","price_state":"stated","total_value":38053112.097,"total_display":"38,053,112.10","total_whole":"38,053,112","shares_owned_after":65474542.0,"shares_owned_after_display":"65,474,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-20","scope":"insider"},{"id":8599090,"accession":"0000929638-23-001185","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000929638-23-001185","line_url":"/filing/0000929638-23-001185#line-3","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":562121.0,"shares_display":"562,121","price_per_share":10.6729,"price_display":"10.67","price_state":"stated","total_value":5999461.2209,"total_display":"5,999,461.22","total_whole":"5,999,461","shares_owned_after":62097896.0,"shares_owned_after_display":"62,097,896","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-17","scope":"insider"},{"id":8599089,"accession":"0000929638-23-001185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-23-001185","line_url":"/filing/0000929638-23-001185#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":841967.0,"shares_display":"841,967","price_per_share":9.958,"price_display":"9.96","price_state":"stated","total_value":8384307.386,"total_display":"8,384,307.39","total_whole":"8,384,307","shares_owned_after":61535775.0,"shares_owned_after_display":"61,535,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-14","filed_date":"2023-04-17","scope":"insider"},{"id":8599086,"accession":"0000929638-23-001185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-001185","line_url":"/filing/0000929638-23-001185#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1193808.0,"shares_display":"1,193,808","price_per_share":9.1602,"price_display":"9.16","price_state":"stated","total_value":10935520.0416,"total_display":"10,935,520.04","total_whole":"10,935,520","shares_owned_after":60693808.0,"shares_owned_after_display":"60,693,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-17","scope":"insider"},{"id":7939778,"accession":"0000929638-23-001057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-001057","line_url":"/filing/0000929638-23-001057#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":12000000.0,"total_display":"12,000,000.00","total_whole":"12,000,000","shares_owned_after":3570872.0,"shares_owned_after_display":"3,570,872","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider"},{"id":8670219,"accession":"0000929638-23-000867","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000929638-23-000867","line_url":"/filing/0000929638-23-000867#line-3","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.1485,"price_display":"10.15","price_state":"stated","total_value":5074250.0,"total_display":"5,074,250.00","total_whole":"5,074,250","shares_owned_after":53500000.0,"shares_owned_after_display":"53,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-16","scope":"insider"},{"id":8670216,"accession":"0000929638-23-000867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-23-000867","line_url":"/filing/0000929638-23-000867#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":10.5955,"price_display":"10.60","price_state":"stated","total_value":2648875.0,"total_display":"2,648,875.00","total_whole":"2,648,875","shares_owned_after":53000000.0,"shares_owned_after_display":"53,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-16","scope":"insider"},{"id":8670211,"accession":"0000929638-23-000867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-23-000867","line_url":"/filing/0000929638-23-000867#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ambrx Biopharma Inc.","issuer_ticker":"AMAM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":9.9531,"price_display":"9.95","price_state":"stated","total_value":2488275.0,"total_display":"2,488,275.00","total_whole":"2,488,275","shares_owned_after":52750000.0,"shares_owned_after_display":"52,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-16","scope":"insider"},{"id":4943930,"accession":"0001567619-21-018789","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-018789","line_url":"/filing/0001567619-21-018789#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP; Chen Bihua; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":1410303.0,"shares_owned_after_display":"1,410,303","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-25","filed_date":"2021-10-27","scope":"insider"},{"id":4529681,"accession":"0001567619-21-018355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-018355","line_url":"/filing/0001567619-21-018355#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Pyxis Oncology, Inc.","issuer_ticker":"PYXS","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Private Healthcare Fund III LP; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":7200000.0,"total_display":"7,200,000.00","total_whole":"7,200,000","shares_owned_after":1118854.0,"shares_owned_after_display":"1,118,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-15","scope":"insider"},{"id":5327673,"accession":"0001567619-21-017389","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-017389","line_url":"/filing/0001567619-21-017389#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP; Chen Bihua; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":1069932.0,"shares_owned_after_display":"1,069,932","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":5417707,"accession":"0001567619-21-014499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-014499","line_url":"/filing/0001567619-21-014499#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Private Healthcare Fund III LP; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":8250000.0,"total_display":"8,250,000.00","total_whole":"8,250,000","shares_owned_after":2252628.0,"shares_owned_after_display":"2,252,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider"},{"id":5417592,"accession":"0001567619-21-012841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-012841","line_url":"/filing/0001567619-21-012841#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Elevation Oncology, Inc.","issuer_ticker":"ELEV","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Chen Bihua","owner_display_name":"Cormorant Asset Management, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":2233168.0,"shares_owned_after_display":"2,233,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-29","filed_date":"2021-07-01","scope":"insider"},{"id":5227502,"accession":"0001567619-21-012781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-012781","line_url":"/filing/0001567619-21-012781#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":11400000.0,"total_display":"11,400,000.00","total_whole":"11,400,000","shares_owned_after":3202200.0,"shares_owned_after_display":"3,202,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":5156542,"accession":"0001567619-21-012510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-012510","line_url":"/filing/0001567619-21-012510#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Chen Bihua; Cormorant Asset Management, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":5225000.0,"total_display":"5,225,000.00","total_whole":"5,225,000","shares_owned_after":984224.0,"shares_owned_after_display":"984,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider"},{"id":4108202,"accession":"0001567619-21-008744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-008744","line_url":"/filing/0001567619-21-008744#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Chen Bihua; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":7650000.0,"total_display":"7,650,000.00","total_whole":"7,650,000","shares_owned_after":2776657.0,"shares_owned_after_display":"2,776,657","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-27","filed_date":"2021-04-29","scope":"insider"},{"id":4562348,"accession":"0001567619-21-008471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-008471","line_url":"/filing/0001567619-21-008471#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Asset Management, LP; Cormorant Private Healthcare Fund III LP; Chen Bihua; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Cormorant Asset Management, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900000.0,"shares_display":"900,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":15300000.0,"total_display":"15,300,000.00","total_whole":"15,300,000","shares_owned_after":3170872.0,"shares_owned_after_display":"3,170,872","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-20","filed_date":"2021-04-22","scope":"insider"},{"id":5496795,"accession":"0001567619-21-007374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-007374","line_url":"/filing/0001567619-21-007374#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Chen Bihua; Cormorant Private Healthcare Fund II, LP; Cormorant Asset Management, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":5114844.0,"shares_owned_after_display":"5,114,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":4562125,"accession":"0001567619-21-006615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-006615","line_url":"/filing/0001567619-21-006615#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Prometheus Biosciences, Inc.","issuer_ticker":"RXDX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Asset Management, LP; Chen Bihua; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Cormorant Asset Management, LP","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":7125000.0,"total_display":"7,125,000.00","total_whole":"7,125,000","shares_owned_after":2223022.0,"shares_owned_after_display":"2,223,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-18","scope":"insider"},{"id":2116179,"accession":"0001567619-20-020222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-020222","line_url":"/filing/0001567619-20-020222#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP; Chen Bihua; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund II, LP","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":425000.0,"shares_display":"425,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":8075000.0,"total_display":"8,075,000.00","total_whole":"8,075,000","shares_owned_after":3270544.0,"shares_owned_after_display":"3,270,544","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001839970","name":"BlossomHill Therapeutics, Inc.","url":"/issuer/0001839970","role":"Ten percent owner","n_filings":1,"first_seen":"2026-08-10","last_seen":"2026-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001821586","name":"MoonLake Immunotherapeutics","url":"/issuer/0001821586","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2023-10-04","last_seen":"2025-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"OnKure Therapeutics, Inc.","url":"/issuer/0001637715","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2025-05-14","last_seen":"2025-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001790340","name":"Immuneering Corp","url":"/issuer/0001790340","role":"Ten percent owner","n_filings":3,"first_seen":"2021-08-05","last_seen":"2024-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001990550","name":"Ambrx Biopharma, Inc.","url":"/issuer/0001990550","role":"Ten percent owner","n_filings":1,"first_seen":"2023-10-25","last_seen":"2023-10-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001836056","name":"Ambrx Biopharma Inc.","url":"/issuer/0001836056","role":"Ten percent owner","n_filings":4,"first_seen":"2023-03-16","last_seen":"2023-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001840439","name":"Biomea Fusion, Inc.","url":"/issuer/0001840439","role":"Ten percent owner","n_filings":2,"first_seen":"2021-04-22","last_seen":"2023-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001851194","name":"Ventyx Biosciences, Inc.","url":"/issuer/0001851194","role":"Ten percent owner","n_filings":1,"first_seen":"2021-10-27","last_seen":"2021-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001782223","name":"Pyxis Oncology, Inc.","url":"/issuer/0001782223","role":"Other","n_filings":1,"first_seen":"2021-10-15","last_seen":"2021-10-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001863127","name":"Tyra Biosciences, Inc.","url":"/issuer/0001863127","role":"Other","n_filings":1,"first_seen":"2021-09-21","last_seen":"2021-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001783032","name":"Elevation Oncology, Inc.","url":"/issuer/0001783032","role":"Ten percent owner","n_filings":1,"first_seen":"2021-07-01","last_seen":"2021-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-30","last_seen":"2021-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Other","n_filings":1,"first_seen":"2021-06-23","last_seen":"2021-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001724979","name":"Rain Therapeutics Inc.","url":"/issuer/0001724979","role":"Other","n_filings":1,"first_seen":"2021-04-29","last_seen":"2021-04-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Other","n_filings":1,"first_seen":"2021-04-01","last_seen":"2021-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001718852","name":"Prometheus Biosciences, Inc.","url":"/issuer/0001718852","role":"Other","n_filings":1,"first_seen":"2021-03-18","last_seen":"2021-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001750284","name":"Olema Pharmaceuticals, Inc.","url":"/issuer/0001750284","role":"Ten percent owner","n_filings":1,"first_seen":"2020-11-23","last_seen":"2020-11-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001817320","retrieved_at":"2026-08-25T13:51:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}